Literature DB >> 19924358

[Development of thoracic surgery over the next 20 years].

H Hoffmann1, H Dienemann.   

Abstract

Thoracic surgery is one of the self-contained surgical disciplines with an above average large potential over the next 20 years. An increase in mortality due to pulmonary diseases is to be expected worldwide. Bronchial carcinoma is the most common diagnosis in thoracic surgery patients and will remain a relevant topic for health politics for many years. However, the adequate treatment of these patients demands a high degree of interdisciplinary cooperation. In the future thoracic surgery will therefore be carried out in centres with an organ-dependent and interdisciplinary structure. From a surgical technical perspective minimally invasive operation strategies will become established for standard interventions, which are indispensible components of the repertoire for thoracic surgery. Thoracic surgery is traditionally a clinically oriented discipline with low academic superstructure and a high backlog demand in nearly all areas of research. It offers a large field of activity for the next scientifically interested generation with excellent chances to become established and succeed in this discipline with a very promising future.

Entities:  

Mesh:

Year:  2009        PMID: 19924358     DOI: 10.1007/s00104-009-1775-z

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  15 in total

1.  Thoracic surgery education--past, present, and future.

Authors:  Fred A Crawford
Journal:  Ann Thorac Surg       Date:  2005-06       Impact factor: 4.330

2.  Patterns of surgical care of lung cancer patients.

Authors:  Alex G Little; Valerie W Rusch; James A Bonner; Laurie E Gaspar; Mark R Green; W Richard Webb; Andrew K Stewart
Journal:  Ann Thorac Surg       Date:  2005-12       Impact factor: 4.330

3.  The influence of hospital volume on survival after resection for lung cancer.

Authors:  P B Bach; L D Cramer; D Schrag; R J Downey; S E Gelfand; C B Begg
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

4.  Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group.

Authors:  Keith S Naunheim; Douglas E Wood; Zab Mohsenifar; Alice L Sternberg; Gerard J Criner; Malcolm M DeCamp; Claude C Deschamps; Fernando J Martinez; Frank C Sciurba; James Tonascia; Alfred P Fishman
Journal:  Ann Thorac Surg       Date:  2006-08       Impact factor: 4.330

5.  Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude.

Authors:  Trond-Eirik Strand; Hans Rostad; Ronald A M Damhuis; Jarle Norstein
Journal:  Thorax       Date:  2007-06-15       Impact factor: 9.139

6.  Hospital volume and late survival after cancer surgery.

Authors:  John D Birkmeyer; Yating Sun; Sandra L Wong; Therese A Stukel
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

7.  Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma.

Authors:  A Scherpereel; P Astoul; P Baas; T Berghmans; H Clayson; P de Vuyst; H Dienemann; F Galateau-Salle; C Hennequin; G Hillerdal; C Le Péchoux; L Mutti; J-C Pairon; R Stahel; P van Houtte; J van Meerbeeck; D Waller; W Weder
Journal:  Eur Respir J       Date:  2009-08-28       Impact factor: 16.671

8.  Impact of hospital volume on operative mortality for major cancer surgery.

Authors:  C B Begg; L D Cramer; W J Hoskins; M F Brennan
Journal:  JAMA       Date:  1998-11-25       Impact factor: 56.272

9.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema.

Authors:  Alfred Fishman; Fernando Martinez; Keith Naunheim; Steven Piantadosi; Robert Wise; Andrew Ries; Gail Weinmann; Douglas E Wood
Journal:  N Engl J Med       Date:  2003-05-20       Impact factor: 91.245

10.  Intraoperative radiofrequency ablation of lung metastases and histologic evaluation.

Authors:  Thomas Schneider; Arne Warth; Esther Herpel; Philipp A Schnabel; Andreas von Deimling; Ralf Eberhardt; Felix J F Herth; Hendrik Dienemann; Hans Hoffmann
Journal:  Ann Thorac Surg       Date:  2009-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.